Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy

NCT06875739 is registered in ClinicalTrials.gov with Fondazione Don Carlo Gnocchi ETS as lead sponsor.

NCT NCT06875739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06875739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
Lead sponsor
Fondazione Don Carlo Gnocchi ETS
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 14, 2025
Completion date
October 1, 2026
Enrollment
310 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, amyotrophic lateral sclerosis, fronto-temporal dementia, neurodegenerative disorders, parkinson disease, parkinsonian disorders